MCWHERTER CHARLES (Chief Science Officer) received a stock award from CYMABAY THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/26/2024ACC: 0001062993-24-001432
Officer· Chief Science Officer
Since Jan 2019
+150.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150.56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+31.94K
Price / share
—
Trade value
—
% of position
212.9%
1/24/2024
15K→46.94K
Total
Net shares
+31.94K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/24/2024 | A · Award | +31.94K | — | — | 212.9% | 15K | 46.94K |
| Total | +31.94K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
118.63K shares
Shares
+118.63K
Strike price
22.85
Held after
118.63K
Exercisable
—
1/24/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock118.63K shares | 1/24/2024 | A · Award | +118.63K | 22.85 | — | 118.63K |